insights_auto
Why is OCEA down 60.00%?
Dive Deeperchevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00020
arrow_downward
-60.00%(-0.00030) 1D
Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCEA...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
38.40K
Volume
59.85K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
38.40K
Volume
59.85K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
News stories
From web sources and news partners
Chart Mill
·
1 hour ago
Discover the top S&P500 movers in Monday's after-hours session.
TradingView
·
1 hour ago
Nasdaq falls ahead of earnings, economic data while oil rallies
24/7 Wall St.
·
39 minutes ago
You Bought VOO to Own the S&P 500. On $500,000, One Chipmaker Is $40,400 of It
JournalArta
·
30 minutes ago
S&P 500 little changed as earnings: Explained
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc